Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)

Abroad (travel likely)RecruitingPHASE2

Conditions

Intrahepatic Cholangiocarcinoma (Icc) · HAIC · Durvalumab

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

West China Hospital, Sichuan University, Chengdu, Sichuan, China
Contact: Study coordinator (yun X Zhang, PHD) · zhangxiaoyun@wchscu.cn · +86-18011410585

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma (Icc)

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer

Intrahepatic Cholangiocarcinoma (Icc) · Gall Bladder Cancer

Abroad (travel likely)RecruitingPHASE2

Tianjin, China

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Intrahepatic Cholangiocarcinoma

Abroad (travel likely)Recruiting

Fuzhou, China

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

Intrahepatic Cholangiocarcinoma

Abroad (travel likely)RecruitingPHASE3

Shanghai, China